🦠 David Lu

David Lu is currently working as a Research Biospecimen Coordinator at Melanoma Institute Australia, where 🦠 David provides operational, logistical, and clinical support for melanoma therapeutic research. Prior to this, David was a Research Assistant at Teva Pharmaceuticals, focusing on specialty R&D for new antibody targets and discovery. 🦠 David has also conducted research as an Honours Student at UNSW and as a Research Intern at National Chiao Tung University. David has a Bachelor of Advanced Science (Honours) in Microbiology/Immunology & Pathology from UNSW and has participated in a research exchange program at National Chiao Tung University.